308 related articles for article (PubMed ID: 30904067)
1. Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease.
Landau SI; Guo X; Velazquez H; Torres R; Olson E; Garcia-Milian R; Moeckel GW; Desir GV; Safirstein R
Kidney Int; 2019 Apr; 95(4):797-814. PubMed ID: 30904067
[TBL] [Abstract][Full Text] [Related]
2. Cumulative DNA damage by repeated low-dose cisplatin injection promotes the transition of acute to chronic kidney injury in mice.
Yamashita N; Nakai K; Nakata T; Nakamura I; Kirita Y; Matoba S; Humphreys BD; Tamagaki K; Kusaba T
Sci Rep; 2021 Oct; 11(1):20920. PubMed ID: 34686727
[TBL] [Abstract][Full Text] [Related]
3. Effects of repeated increasing doses of cisplatin as models of acute kidney injury and chronic kidney disease in rats.
Al Za'abi M; Al Salam S; Al Suleimani Y; Ashique M; Manoj P; Nemmar A; Ali BH
Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):249-259. PubMed ID: 32936352
[TBL] [Abstract][Full Text] [Related]
4. Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation.
Guo X; Xu L; Velazquez H; Chen TM; Williams RM; Heller DA; Burtness B; Safirstein R; Desir GV
J Am Soc Nephrol; 2022 Feb; 33(2):342-356. PubMed ID: 34921111
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer-kidney cross talk induces kidney injury, interstitial fibrosis, and enhances cisplatin-induced nephrotoxicity.
Orwick A; Sears SM; Sharp CN; Doll MA; Shah PP; Beverly LJ; Siskind LJ
Am J Physiol Renal Physiol; 2023 Mar; 324(3):F287-F300. PubMed ID: 36727944
[TBL] [Abstract][Full Text] [Related]
6. Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity.
Li HY; Yang S; Li JC; Feng JX
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30455396
[TBL] [Abstract][Full Text] [Related]
7. Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease.
Sharp CN; Doll MA; Megyesi J; Oropilla GB; Beverly LJ; Siskind LJ
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F161-F172. PubMed ID: 29384415
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation.
Li C; Xie N; Li Y; Liu C; Hou FF; Wang J
Free Radic Biol Med; 2019 Jan; 130():512-527. PubMed ID: 30447351
[TBL] [Abstract][Full Text] [Related]
9. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; CippĂ P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
[TBL] [Abstract][Full Text] [Related]
10. Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells.
Fu Y; Cai J; Li F; Liu Z; Shu S; Wang Y; Liu Y; Tang C; Dong Z
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1582-F1592. PubMed ID: 31532246
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury.
Holditch SJ; Brown CN; Lombardi AM; Nguyen KN; Edelstein CL
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226747
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin nephrotoxicity: new insights and therapeutic implications.
Tang C; Livingston MJ; Safirstein R; Dong Z
Nat Rev Nephrol; 2023 Jan; 19(1):53-72. PubMed ID: 36229672
[TBL] [Abstract][Full Text] [Related]
13. Divergent effects of AKI to CKD models on inflammation and fibrosis.
Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
[TBL] [Abstract][Full Text] [Related]
14. Single-Nucleus Transcriptional Profiling of Chronic Kidney Disease after Cisplatin Nephrotoxicity.
Ma Z; Hu X; Ding HF; Zhang M; Huo Y; Dong Z
Am J Pathol; 2022 Apr; 192(4):613-628. PubMed ID: 35092726
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
[TBL] [Abstract][Full Text] [Related]
16. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
Katagiri D; Hamasaki Y; Doi K; Negishi K; Sugaya T; Nangaku M; Noiri E
Kidney Int; 2016 Feb; 89(2):374-85. PubMed ID: 26535996
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin nephrotoxicity as a model of chronic kidney disease.
Shi M; McMillan KL; Wu J; Gillings N; Flores B; Moe OW; Hu MC
Lab Invest; 2018 Aug; 98(8):1105-1121. PubMed ID: 29858580
[TBL] [Abstract][Full Text] [Related]
18. N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
Small DM; Sanchez WY; Roy SF; Morais C; Brooks HL; Coombes JS; Johnson DW; Gobe GC
Am J Physiol Renal Physiol; 2018 May; 314(5):F956-F968. PubMed ID: 29357409
[TBL] [Abstract][Full Text] [Related]
19. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells.
Zhang B; Ramesh G; Norbury CC; Reeves WB
Kidney Int; 2007 Jul; 72(1):37-44. PubMed ID: 17396112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]